Načítá se...
TET2 promotes anti‐tumor immunity by governing G‐MDSCs and CD8(+) T‐cell numbers
The host immune response is a fundamental mechanism for attenuating cancer progression. Here we report a role for the DNA demethylase and tumor suppressor TET2 in host anti‐tumor immunity. Deletion of Tet2 in mice elevates IL‐6 levels upon tumor challenge. Elevated IL‐6 stimulates immunosuppressive...
Uloženo v:
| Vydáno v: | EMBO Rep |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7534639/ https://ncbi.nlm.nih.gov/pubmed/32929842 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embr.201949425 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|